Article · 9 Feb 2026
Conference abstractPublished 17 Oct 2016
Cur cumin has a dual effect on targeting the lung cancer cell lines
Apoptosis Research Centre, National University of Ireland Galway
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Exposure to arsenic is one of the major causes of lung cancer due to production of Reactive Oxygen Species (ROS). Herbal medicine is a new approach used for prevention or treatment of cancers. Among various herbal compounds, a lot of attention has been paid to cur cumin, as antioxidant, anti-proliferative, anti-carcinogenic and anti-tumour and pro-apoptotic properties of cur cumin have been well studied. In the present study, we investigated the effects of cur cumin on lung cancer cell lines and arsenic-treated lung cancer cell lines, originated from different stages of lung cancer development. Here, we measured ROS generation and caspase 3/7 activity for both cur cumin-treated cell lines and those co-treated with arsenic and cur cumin. Then, we studied lipid peroxidation, intracellular ATP content, and cytochrome c release to further investigate how ROS generation and cur cumin exert synergistic effects and direct cells toward apoptosis. According to our data, cur cumin has a dual effect on ROS generation which is dependent on specific concentration as a threshold and seems to induce apoptosis by two different mechanisms. Moreover, for the first time we report that cur cumin delays the drop in ATP levels in these cell lines and hence provides required energy for apoptosis process. Furthermore, western blot analysis reveals that release of cytochrome c is highest when ATP begins to drop in the presence of cur cumin. To sum it up, it seems that curcumin is strong candidate for prevention or treatment of lung cancer, especially at stage 2.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Amin Tashakor”
- BylineArticles whose byline prints “Mahshid H-Dehkordi”
